EUVIMEDOdkrijte EUVIMED
Übersichtsarbeit

Berberine and berberine nanoformulations in cancer therapy: Focusing on lung cancer

Chou-Yi Hsu, Harikumar Pallathadka iD, Jitendra Gupta iD, Haowei Ma, Hamzah H K Al-Shukri, A K Kareem, Ahmed Hussein Zwamel, Yasser Fakri Mustafa iD

Phytotherapy Research · 2024

DOI: 10.1002/ptr.8255 ↗

At a glance

Übersichtsarbeit in Phytotherapy Research, 2024. Written by Chou-Yi Hsu and 7 co-authors. Institution: Thunderbird School of Global Management, Arizona State University Tempe Campus, Phoenix, Arizona, USA. Major MEDLINE topics: Berberine, Lung Neoplasms, Nanoparticles. Cited 60 times so far (Crossref); 140 references.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

Lung cancer is the second most prevalent cancer and ranks first in cancer‐related death worldwide. Due to the resistance development to conventional cancer therapy strategies, including chemotherapy, radiotherapy, targeted therapy, and immunotherapy, various natural products and their extracts have been revealed as alternatives. Berberine (BBR), which is present in the stem, root, and bark of various trees, could exert anticancer activities by regulating tumor cell proliferation, apoptosis, autophagy, metastasis, angiogenesis, and immune responses via modulating several signaling pathways within the tumor microenvironment. Due to its poor water solubility, poor pharmacokinetics/bioavailability profile, and extensive p‐glycoprotein‐dependent efflux, BBR application in (pre) clinical studies is restricted. To overcome these limitations, BBR can be encapsulated in nanoparticle (NP)‐based drug delivery systems, as monotherapy or combinational therapy, and improve BBR therapeutic efficacy. Nanoformulations also facilitate the selective delivery of BBR into lung cancer cells. In addition to the anticancer activities of BBR, especially in lung cancer, here we reviewed the BBR nanoformulations, including polymeric NPs, metal‐based NPs, carbon nanostructures, and others, in the treatment of lung cancer.

Subjects

MeSH terms (MEDLINE)

BerberineLung NeoplasmsNanoparticlesHumansDrug Delivery SystemsAnimalsAntineoplastic Agents, Phytogenic

Author keywords

berberinedrug deliverylung cancernanoformulationsnanoparticle

Substances

BerberineAntineoplastic Agents, Phytogenic

Authors and institutions

  • Thunderbird School of Global Management, Arizona State University Tempe Campus, Phoenix, Arizona, USA.
  • Manipur International University, Imphal, Manipur, India.
  • Institute of Pharmaceutical Research, GLA University, Mathura, India.
  • Department of Mechanical and Aerospace Engineering, Case Western Reserve University, Cleveland, Ohio, USA.
  • Veterinary medicine college, Al-Qasim Green University, Babylon, Iraq.
  • Biomedical Engineering Department, College of Engineering and Technologies, Al-Mustaqbal University, Hillah, Iraq.

ORCID profiles: Harikumar Pallathadka, Jitendra Gupta, Yasser Fakri Mustafa

Cite

APA

Hsu, C. Y., Pallathadka, H., Gupta, J., Ma, H., Al-Shukri, H. H. K., Kareem, A. K., Zwamel, A. H., & Mustafa, Y. F. (2024). Berberine and berberine nanoformulations in cancer therapy: Focusing on lung cancer. Phytotherapy Research. https://doi.org/10.1002/ptr.8255

Vancouver

Hsu CY, Pallathadka H, Gupta J, Ma H, Al-Shukri HHK, Kareem AK, et al. Berberine and berberine nanoformulations in cancer therapy: Focusing on lung cancer. Phytotherapy Research. 2024. doi:10.1002/ptr.8255

BibTeX
@article{Hsu2024,
  author = {Hsu, Chou-Yi and Pallathadka, Harikumar and Gupta, Jitendra and Ma, Haowei and Al-Shukri, Hamzah H K and Kareem, A K and Zwamel, Ahmed Hussein and Mustafa, Yasser Fakri},
  title = {Berberine and berberine nanoformulations in cancer therapy: Focusing on lung cancer},
  journal = {Phytotherapy Research},
  year = {2024},
  doi = {10.1002/ptr.8255}
}
Start for free →